Home
/
Zenas BioPharma, Inc.
/
Financials
/
Quarterly
Zenas BioPharma, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Zenas BioPharma, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$0
Nov 12, 2025
Q2
2025
Jun 30, 2025
$0
Aug 12, 2025
Q1
2025
Mar 31, 2025
$10.00M
May 15, 2025
Q3
2025
Sep 30, 2024
$0
Nov 12, 2025
Q2
2025
Jun 30, 2024
$0
Aug 12, 2025
Q3
2024
Sep 30, 2023
$50.00M
Nov 12, 2024
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$10.00M
Nov 12, 2025
Q2
2025
Jun 30, 2025
$10.00M
Aug 12, 2025
Q1
2025
Mar 31, 2025
$10.00M
May 15, 2025
Q3
2024
Sep 30, 2023
$50.00M
Nov 12, 2024
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($51.50M)
Nov 12, 2025
Q3
2025
Jun 30, 2025
($52.22M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($52.22M)
Aug 12, 2025
Q3
2025
Mar 31, 2025
($33.57M)
Nov 12, 2025
Q2
2025
Mar 31, 2025
($33.57M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($33.57M)
May 15, 2025
Q3
2025
Sep 30, 2024
($38.61M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($37.98M)
Aug 12, 2025
Q3
2025
Jun 30, 2024
($37.98M)
Nov 12, 2025
Q1
2025
Mar 31, 2024
($27.80M)
May 15, 2025
Q3
2025
Mar 31, 2024
($27.80M)
Nov 12, 2025
Q2
2025
Mar 31, 2024
($27.80M)
Aug 12, 2025
Q3
2024
Sep 30, 2023
$35.61M
Nov 12, 2024
Q3
2024
Jun 30, 2023
($29.05M)
Nov 12, 2024
Q3
2024
Mar 31, 2023
($19.10M)
Nov 12, 2024
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($52.58M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($55.16M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($37.33M)
May 15, 2025
Q3
2025
Sep 30, 2024
($40.98M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($39.70M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($27.58M)
May 15, 2025
Q3
2024
Sep 30, 2023
$35.62M
Nov 12, 2024